Laboratory and clinical data indicate an antitumor effect of 1,25(OH)(
2) vitamin D (1,25(OH)(2)D) on prostate cancer. High calcium intake su
ppresses formation of 1,25(OH)(2)D from 25(OH)D, thereby decreasing th
e 1,25(OH)(2)D level. Ingestion of fructose reduces plasma phosphate t
ransiently, and hypophosphatemia stimulates 1,25(OH)(2)D production. W
e thus conducted a prospective study among 47,781 men of the Health Pr
ofessionals Follow-Up Study free of cancer in 1986 to examine whether
calcium and fructose intake influenced risk of prostate cancer. Betwee
n 1986 and 1994, 1369 non-stage A1 and 423 advanced (extraprostatic) c
ases of prostate cancer were diagnosed. Higher consumption of calcium
was related to advanced prostate cancer [multivariate relative risk (R
R), 2.97; 95% confidence interval (CI), 1.61-5.50 for intakes greater
than or equal to 2000 mg/day versus <500 mg/day; P, trend, 0.002] and
metastatic prostate cancer (RR, 4.57; major source of calcium, CI, 1.8
8-11.1; P, trend, <0.001). Calcium from food sources and from 1,25(OH)
(2)D levels. supplements independently increased risk. High fructose i
ntake was related to a lower risk of advanced prostate cancer (multiva
riate RR, 0.51; CI, 0.33-0.80, for intakes >70 versus less than or equ
al to 40 g/day; P, trend, 0.007). Fruit intake was inversely associate
d with risk of advanced prostate cancer (RR, 0.63; 95% CI, 0.43-0.93;
for >5 versus less than or equal to 1 serving per day), and this assoc
iation was accounted for by fructose intake. Non-fruit sources of fruc
tose similarly predicted lower risk of advanced prostate cancer. A mod
erate positive association between energy-adjusted fat intake and adva
nced prostate cancer was attenuated and no longer statistically signif
icant when controlled for calcium and fructose. Our findings provide i
ndirect evidence for a protective influence of high 1,25(OH)(2)D level
s on prostate cancer and support increased fruit consumption and avoid
ance of high calcium intake to reduce the risk of advanced prostate ca
ncer.